Jeff A Lehmen, MD | |
2505 Mission Dr, Suite 200, Jefferson City, MO 65109-9508 | |
(573) 681-3759 | |
(573) 681-3659 |
Full Name | Jeff A Lehmen |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 19 Years |
Location | 2505 Mission Dr, Jefferson City, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326134925 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | T2005018425 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Central Missouri Home Health | Jefferson city, MO | Home health agency |
Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
Lake Regional Health System | Osage beach, MO | Hospital |
Bothwell Regional Health Center | Sedalia, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Physical Therapy Spine And Sports Medicine Llc | 3173654936 | 91 |
Shea Physical Therapy Specialists Llc | 6204245194 | 106 |
Ssm Regional Health Services | 8921917352 | 55 |
News Archive
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 1 days ago
Entity Name | Ssm Regional Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336555275 PECOS PAC ID: 8921917352 Enrollment ID: O20040107000402 |
News Archive
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 1 days ago
Entity Name | Ssm Regional Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649217837 PECOS PAC ID: 8921917352 Enrollment ID: O20070213000635 |
News Archive
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jeff A Lehmen, MD 2505 Mission Dr, Suite 200, Jefferson City, MO 65109-9508 Ph: (573) 681-3759 | Jeff A Lehmen, MD 2505 Mission Dr, Suite 200, Jefferson City, MO 65109-9508 Ph: (573) 681-3759 |
News Archive
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
› Verified 1 days ago
Dr. John D Spears, D.O. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1616 Southridge Dr, Ste 202, Jefferson City, MO 65109 Phone: 573-635-0401 Fax: 573-635-6715 | |
Joyce Marie Wilson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1225 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-8000 Fax: 573-556-1710 | |
Dr. John J. Krautmann, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1225 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-8000 | |
Lauren Platt Cook, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5500 Fax: 573-632-4998 | |
Dr. Michael J. Snyder, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1225 West Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-8000 Fax: 573-556-1710 | |
William Blake Rodgers, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2505 Mission Dr, Suite 200, Jefferson City, MO 65109 Phone: 573-681-3759 Fax: 573-681-3659 |